Anxiolytic impact of cognitive behavioural therapy for insomnia in patients with co-morbid insomnia and generalized anxiety disorder

被引:0
|
作者
Lau, Parky [1 ]
Starick, Elisha [1 ]
Carney, Colleen E. [1 ]
机构
[1] Toronto Metropolitan Univ, Dept Psychol, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Anxiety; CBT; Insomnia; Predictors of recovery;
D O I
10.1017/S1352465823000656
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Cognitive behavioural therapy for insomnia (CBT-I) is an effective treatment for chronic insomnia that also improves non-sleep symptoms, such as mood and anxiety. Identifying sleep-specific variables that predict anxiety change after CBT-I treatment may support alternative strategies when people with generalized anxiety disorder (GAD) do not improve from standard GAD treatment.Aims: To investigate CBT-I on changes in anxiety and evaluate whether changes in sleep-specific variables predict anxiety outcomes.Methods: Seventy-two participants presenting with insomnia and GAD (GAD-I) completed four sessions of CBT-I. Participants completed daily diaries and self-report measures at baseline and post-treatment.Results: CBT-I in a co-morbid GAD-I sample was associated with medium reductions in anxiety, and large reductions in insomnia severity. Subjective insomnia severity and tendencies to ruminate in response to fatigue predicted post-treatment anxiety change, in addition to younger age and lower baseline anxiety.Conclusions: The findings suggest that younger GAD-I participants with moderate anxiety symptoms may benefit most from the anxiety-relieving impact of CBT-I. Reducing perceived insomnia severity and the tendency to ruminate in response to fatigue may support reductions in anxiety in those with GAD-I.
引用
收藏
页码:456 / 460
页数:5
相关论文
共 50 条
  • [1] Insomnia severity in patients with primary insomnia and insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Roth, Thomas
    Wilson, Phebe
    Schaefer, Kendyl
    Pfleeger, Kimberly
    Rubens, Robert
    Fava, Maurizio
    Pollack, Mark
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 85S
  • [2] Cognitive behavioural therapy for insomnia for patients with co-morbid generalized anxiety disorder: an open trial on clinical outcomes and putative mechanisms
    Jansson-Frojmark, Markus
    Jacobson, Kalle
    BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2021, 49 (05) : 540 - 555
  • [3] The effectiveness of cognitive behavioural therapy for insomnia patients with co-morbid obstructive sleep apnea
    Lack, L.
    Sweetman, A.
    Smith, S.
    Dunn, N.
    Catcheside, P.
    Antic, N.
    Chai-Coetzer, C. -L.
    Douglas, J.
    O'Grady, A.
    Paul, D.
    Mc Evoy, D.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 45 - 45
  • [4] Cognitive processes in the maintenance of insomnia and co-morbid anxiety
    Zwi, R
    Shawe-Taylor, M
    Murray, J
    BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2005, 33 (03) : 333 - 342
  • [5] Baseline insomnia severity in patients with primary insomnia and insomnia co-morbid with major depressive disorder, generalized anxiety disorder, perimenopausal transition or rheumatoid arthritis
    Roth, T.
    Wilson, P.
    Schaefer, K.
    Rubens, R.
    Walsh, J.
    Krystal, A.
    SLEEP, 2007, 30 : A247 - A247
  • [6] Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, M.
    Pollack, M.
    Rubens, R.
    Amato, D.
    Kostal, A.
    Hayduk, R.
    McCall, W.
    SLEEP, 2007, 30 : A329 - A330
  • [7] Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, Maurizio
    Pollack, Mark
    Rubens, Robert
    Amato, David
    Krystal, Andrew
    Hayduk, Roza
    McCall, W. Vaughn
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 84S
  • [8] Relative effect sizes of eszopiclone treatment for insomnia in patients with primary insomnia and insomnia co-morbid with major depressive disorder, generalized anxiety disorder, perimenopausal transition or rheumatoid arthritis
    Schaefer, K.
    McCall, W.
    Krystal, A.
    Rubens, R.
    Wilson, P.
    Pfleeger, K.
    Roth, T.
    SLEEP, 2007, 30 : A243 - A244
  • [9] Changes in sleep outcomes with hypnotic placebo in patients with primary insomnia (PI) and insomnia co-morbid with major derpessive disorder (MDD) or generalized anxiety disorder (GAD)
    Rubens, Robert
    McCall, W. Vaughn
    Wilson, Phebe
    Schaefer, Kendyl
    Fava, Maurizio
    Pollack, Mark
    Roth, Thomas
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 85S - 85S
  • [10] Adapting a cognitive behavioural therapy for insomnia intervention for adolescents with co-morbid mental health: A Delphi study
    McCrory, Stephanie
    Crawford, Megan
    MacMahon, Kenneth
    Ross, Carey
    Mistry, Dinaish
    Mohanty, Dipalika
    Chadwick, Kai
    Fleming, Leanne
    JOURNAL OF SLEEP RESEARCH, 2024, 33